女性性别与金黄色葡萄球菌菌血症患者管理及死亡率的关联
本研究为金黄色葡萄球菌菌血症前瞻性队列的事后分析,纳入1994至2020年杜克大学医学中心3384例成人单一菌种感染患者,女性1431例(42%)。女性接受抗菌治疗时间更短、经食管超声心动图检查更少,但校正混杂后女性性别与90天死亡率无独立关联(校正HR 0.98,95%CI 0.85-1.13)。
要点
- 女性金黄色葡萄球菌菌血症患者中黑人比例、血液透析依赖比例及MRSA感染比例均高于男性。
- 女性接受抗菌治疗中位时间短于男性,且经食管超声心动图检查比例低于男性。
- 校正混杂因素后,女性性别与90天死亡率无独立关联(校正HR 0.98,95%CI 0.85-1.13)。
核心结论
- 尽管患者特征、疾病特征和管理存在显著差异,女性和男性金黄色葡萄球菌菌血症患者的死亡风险相似。
研究设计与样本
- 本研究为金黄色葡萄球菌菌血症组前瞻性队列研究的事后分析,纳入1994年至2020年在杜克大学医学中心收治的成人单一菌种金黄色葡萄球菌菌血症患者。
- 共纳入3384例患者,其中女性1431例(42%),男性1953例。
- 采用单变量和多变量Cox回归分析评估女性和男性在管理与死亡率方面的差异。
主要发现
- 女性较男性更常为黑人(581/1431[41%] vs 620/1953[32%],p<0.001)。
- 女性较男性更常依赖血液透析(309/1424[22%] vs 334/1940[17%],p=0.001)。
- 女性较男性更常感染耐甲氧西林金黄色葡萄球菌(MRSA)(女性697/1410[49%] vs 男性840/1925[44%],p=0.001)。
- 女性接受抗菌治疗的中位时间短于男性(24天[四分位距14-42] vs 28天[四分位距14-45],p=0.005)。
- 女性接受经食管超声心动图检查的比例低于男性(495/1430[35%] vs 802/1952[41%],p<0.001)。
关键数值与推荐
- 女性90天死亡388/1431(27%),男性491/1953(25%),单变量分析p=0.204。
- 多变量分析中女性校正风险比(HR)为0.98(95%CI 0.85-1.13)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The association of biological female sex with outcome in patients with Staphylococcus aureus bacteraemia remains unresolved. The aim of this study was to determine the independent association of female sex with management and mortality in patients with S. aureus bacteraemia. METHODS: This is a post hoc analysis of prospectively collected data from the S. aureus Bacteraemia Group Prospective Cohort Study. Adult patients with monomicrobial S. aureus bacteraemia at Duke University Medical Center were enrolled from 1994 to 2020. Univariable and multivariable Cox regression analyses were performed to assess differences in management and mortality between females and males. RESULTS: Among 3384 patients with S. aureus bacteraemia, 1431 (42%) were women. Women were, as compared with men, more often Black (581/1431 [41%] vs. 620/1953 [32%], p < 0.001), haemodialysis dependent (309/1424 [22%] vs. 334/1940 [17%], p 0.001) and more likely to be infected with methicillin-resistant S. aureus (MRSA) (697/1410 [49%] MRSA in women vs. 840/1925 [44%] MRSA in men, p 0.001). Women received shorter durations of antimicrobial treatment (median 24 [interquartile range 14-42] vs. 28 [interquartile range 14-45] days, p 0.005), and were less likely to undergo transesophageal echocardiography as compared with men (495/1430 [35%] vs. 802/1952 [41%], p < 0.001). Despite these differences, female sex was not associated with 90-day mortality in either univariable (388/1431 [27%] in women vs. 491/1953 [25%] in men, p 0.204) or multivariable analysis (adjusted hazard ratio for women 0.98 [95% CI, 0.85-1.13]). DISCUSSION: Despite significant differences in patient characteristics, disease characteristics, and management, women and men with S. aureus bacteraemia have a similar mortality risk.
引用
- Westgeest AC, Ruffin F, Kair JL, et al. The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2023. PMID: 37321394. doi:10.1016/j.cmi.2023.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。